SEARCH RESULTS FOR: "Tag: ABBV"
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2019(2)
2018(10)
2017(4)
2016(5)
2015(10)
2014(8)
CATEGORIES
Analyst Downgrades(1)
Analyst Update(4)
Analyst Upgrades(2)
Bernie's Content(1)
Buzz Stocks(4)
By the Numbers(1)
Early Edge(1)
Earnings Preview(1)
Expectational Analysis(1)
General(12)
Indicator of the Week(1)
Intraday Option Activity(1)
Midday Market Check(2)
Opening View(2)
Quantitative Analysis(1)
Stock Market News(1)
Stocks On the Move(7)
Technical Analysis(2)
Unusual Trading Activity(1)
Cantor Targets 52% Upside for Voyager Therapeutics Stock
https://www.schaeffersresearch.com/content/news/2019/03/06/cantor-targets-52-upside-for-voyager-therapeutics-stock
3/6/2019 9:54 AM
The shares of Voyager Therapeutics Inc (NASDAQ:VYGR) jumped out of the gate, after Cantor Fitzgerald initiated coverage with an "outperform" rating and a $27 price target -- a 52% premium to last nig...
Analysts Target Major Upside for Red-Hot Gene Therapy Stocks
https://www.schaeffersresearch.com/content/news/2019/02/25/analysts-target-major-upside-for-red-hot-gene-therapy-stocks
2/25/2019 3:34 PM
Stocks are trading higher today as Wall Street reacts to positive U.S.-China trade news. Among individual names making notable moves are gene therapy specialists uniQure NV (NASDAQ:QURE) and Voyage...
Kickback Accusations Put AbbVie on Track for 4th Straight Loss
https://www.schaeffersresearch.com/content/news/2018/09/19/kickback-accusations-put-abbvie-on-track-for-4th-straight-loss
9/19/2018 10:09 AM
AbbVie Inc (NYSE:ABBV) is in hot water today, after the California Department of Insurance yesterday sued the pharmaceutical name for allegedly providing kickbacks to health insurance providers. The...
Why Now's the Time to Trade the AbbVie Dip
https://www.schaeffersresearch.com/content/analysis/2018/09/11/why-nows-the-time-to-trade-the-abbvie-dip
9/11/2018 2:34 PM
The shares of AbbVie Inc (NYSE:ABBV) have had an uninspiring summer, trading in a choppy sideways range below the $100 level since May. While a recent Food and Drug Administration (FDA) approval was u...
Another FDA Approval Lifts AbbVie Shares
https://www.schaeffersresearch.com/content/news/2018/08/27/another-fda-approval-lifts-abbvie-shares
8/27/2018 9:36 AM
Shares of AbbVie Inc (NYSE:ABBV) are soaring in early trading after the company's non-chemotherapy cancer treatment was approved by the Food and Drug Administration (FDA). The company's IMBRUVICA, in...
Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.
More About
Schaeffer's
Contact
Us
Partner Center